Hertz CEO ‘encouraged’ by Ackman’s ‘significant’ stake in the company

Hertz CEO ‘encouraged’ by Ackman’s ‘significant’ stake in the company

A Hertz Tesla electric vehicle is displayed during the Hertz Corporation IPO at the Nasdaq Market site in Times Square in New York City, U.S., November 9, 2021.  Brendan Mcdermid | Reuters Hertz Global CEO Gil West is “encouraged” and “energized” by prominent investor Bill Ackman taking a “significant” position in the post-bankrupt rental car … Read more

(CHA) starts trading on the Nasdaq

(CHA) starts trading on the Nasdaq

People shopping at a Chagee store in Shanghai, China, on Oct. 18, 2023. Costfoto | Nurphoto | Getty Images Shares of Chinese tea chain Chagee climbed 20% during its public market debut on Thursday, as the company plans a U.S. launch despite trade tensions between Washington and Beijing. The stock, which is trading on the … Read more

UnitedHealth’s guidance cut may mean trouble for more insurers

UnitedHealth’s guidance cut may mean trouble for more insurers

The logo of UnitedHealth appears on the side of one of its office buildings in Santa Ana, California, on April 13, 2020. Mike Blake | Reuters UnitedHealth Group‘s stock sank 20% on Thursday after the company slashed its annual profit forecast, citing higher-than-expected medical costs in its privately run Medicare plans.  Those bleak results from … Read more

OpenAI looked at Cursor before considering deal with rival Windsurf

OpenAI looked at Cursor before considering deal with rival Windsurf

OpenAI CEO Sam Altman looks on during an event at the startup campus Station F, on the sidelines of the Artificial Intelligence Action Summit, in Paris on Feb. 11, 2025. Aurelien Morissard | AFP | Getty Images Before entering into talks to acquire artificial intelligence code-writing startup Windsurf, OpenAI looked at buying another option: Cursor. … Read more

Eli Lilly weight loss pill orforglipron clears first late-stage trial

Eli Lilly weight loss pill orforglipron clears first late-stage trial

Eli Lilly on Thursday said its daily obesity pill met the company’s goals in the first of several late-stage trials, helping patients with Type 2 diabetes lower their blood sugar and body weight and showing safety comparable with popular injections on the market.  The trial results are among the pharmaceutical industry’s most closely watched studies … Read more